These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

789 related articles for article (PubMed ID: 31404802)

  • 1. Association between cognitive function and performance on effort based decision making in patients with major depressive disorder treated with Vortioxetine.
    Subramaniapillai M; Mansur RB; Zuckerman H; Park C; Lee Y; Iacobucci M; Cao B; Ho R; Lin K; Phan L; McIntyre RS
    Compr Psychiatry; 2019 Oct; 94():152113. PubMed ID: 31404802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effort-based decision-making is affected by overweight/obesity in major depressive disorder.
    Mansur RB; Subramaniapillai M; Zuckerman H; Park C; Iacobucci M; Lee Y; Tuineag M; Hawco C; Frey BN; Rasgon N; Brietzke E; McIntyre RS
    J Affect Disord; 2019 Sep; 256():221-227. PubMed ID: 31181378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Motivational deficits in effort-based decision making in individuals with subsyndromal depression, first-episode and remitted depression patients.
    Yang XH; Huang J; Zhu CY; Wang YF; Cheung EF; Chan RC; Xie GR
    Psychiatry Res; 2014 Dec; 220(3):874-82. PubMed ID: 25262638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vortioxetine improves symptomatic and functional outcomes in major depressive disorder: A novel dual outcome measure in depressive disorders.
    Christensen MC; Loft H; McIntyre RS
    J Affect Disord; 2018 Feb; 227():787-794. PubMed ID: 29689693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diminished caudate and superior temporal gyrus responses to effort-based decision making in patients with first-episode major depressive disorder.
    Yang XH; Huang J; Lan Y; Zhu CY; Liu XQ; Wang YF; Cheung EF; Xie GR; Chan RC
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():52-9. PubMed ID: 26192817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Efficacy of Vortioxetine on Anhedonia in Patients With Major Depressive Disorder.
    Cao B; Park C; Subramaniapillai M; Lee Y; Iacobucci M; Mansur RB; Zuckerman H; Phan L; McIntyre RS
    Front Psychiatry; 2019; 10():17. PubMed ID: 30766492
    [No Abstract]   [Full Text] [Related]  

  • 7. Cognitive-functional relationships in major depressive disorder: Crucial data from a Ukrainian open-label study of vortioxetine versus escitalopram.
    Levada OA; Troyan AS
    J Affect Disord; 2019 May; 250():114-122. PubMed ID: 30852363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, double-blind, placebo-controlled study to assess the efficacy and safety of vortioxetine in Japanese patients with major depressive disorder.
    Inoue T; Sasai K; Kitagawa T; Nishimura A; Inada I
    Psychiatry Clin Neurosci; 2020 Feb; 74(2):140-148. PubMed ID: 31725942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in sleep predict changes in depressive symptoms in depressed subjects receiving vortioxetine: An open-label clinical trial.
    Cao B; Park C; Rosenblat JD; Chen Y; Iacobucci M; Subramaniapillai M; Mansur RB; Zuckerman H; Lee Y; McIntyre RS
    J Psychopharmacol; 2019 Nov; 33(11):1388-1394. PubMed ID: 31530216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effort-based decision-making in major depressive disorder: a translational model of motivational anhedonia.
    Treadway MT; Bossaller NA; Shelton RC; Zald DH
    J Abnorm Psychol; 2012 Aug; 121(3):553-8. PubMed ID: 22775583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term functioning outcomes are predicted by cognitive symptoms in working patients with major depressive disorder treated with vortioxetine: results from the AtWoRC study.
    Chokka P; Bougie J; Proulx J; Tvistholm AH; Ettrup A
    CNS Spectr; 2019 Dec; 24(6):616-627. PubMed ID: 30802419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment effects on residual cognitive symptoms among partially or fully remitted patients with major depressive disorder: A randomized, double-blinded, exploratory study with vortioxetine.
    Nierenberg AA; Loft H; Olsen CK
    J Affect Disord; 2019 May; 250():35-42. PubMed ID: 30826492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pain and major depressive disorder: Associations with cognitive impairment as measured by the THINC-integrated tool (THINC-it).
    Cha DS; Carmona NE; Mansur RB; Lee Y; Park HJ; Rodrigues NB; Subramaniapillai M; Rosenblat JD; Pan Z; Lee JH; Lee J; Almatham F; Alageel A; Shekotikhina M; Zhou AJ; Rong C; Harrison J; McIntyre RS
    Scand J Pain; 2017 Apr; 15():62-67. PubMed ID: 28850348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment in Work Productivity and the Relationship with Cognitive Symptoms (AtWoRC): primary analysis from a Canadian open-label study of vortioxetine in patients with major depressive disorder (MDD).
    Chokka P; Bougie J; Rampakakis E; Proulx J
    CNS Spectr; 2019 Jun; 24(3):338-347. PubMed ID: 29792585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cognitive effort expenditure for rewards task (C-EEfRT): A novel measure of willingness to expend cognitive effort.
    Lopez-Gamundi P; Wardle MC
    Psychol Assess; 2018 Sep; 30(9):1237-1248. PubMed ID: 29620381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Worth the 'EEfRT'? The effort expenditure for rewards task as an objective measure of motivation and anhedonia.
    Treadway MT; Buckholtz JW; Schwartzman AN; Lambert WE; Zald DH
    PLoS One; 2009 Aug; 4(8):e6598. PubMed ID: 19672310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of vortioxetine on cognitive dysfunction in patients with inadequate response to current antidepressants in major depressive disorder: A short-term, randomized, double-blind, exploratory study versus escitalopram.
    Vieta E; Sluth LB; Olsen CK
    J Affect Disord; 2018 Feb; 227():803-809. PubMed ID: 29673132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost per successfully treated patient for vortioxetine versus duloxetine in adults with major depressive disorder: an analysis of the complete symptoms of depression and functional outcome.
    Christensen MC; Munro V
    Curr Med Res Opin; 2018 Apr; 34(4):593-600. PubMed ID: 29235884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of vortioxetine on functional capacity across different levels of functional impairment in patients with major depressive disorder: a University of California, San Diego Performance-based Skills Assessment (UPSA) analysis.
    Jacobson W; Zhong W; Nomikos GG; Christensen MC; Kurre Olsen C; Harvey PD
    Curr Med Res Opin; 2020 Jan; 36(1):117-124. PubMed ID: 31422713
    [No Abstract]   [Full Text] [Related]  

  • 20. Inefficient effort allocation and negative symptoms in individuals with schizophrenia.
    McCarthy JM; Treadway MT; Bennett ME; Blanchard JJ
    Schizophr Res; 2016 Feb; 170(2-3):278-84. PubMed ID: 26763628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.